Loading...
XSWX
SKAN
Market cap2.09bUSD
Jul 31, Last price  
74.80CHF
1D
-1.84%
1Q
7.32%
IPO
-14.51%
Name

SKAN Group AG

Chart & Performance

D1W1MN
No data to show
P/E
43.34
P/S
4.65
EPS
1.73
Div Yield, %
0.47%
Shrs. gr., 5y
16.90%
Rev. gr., 5y
149.23%
Revenues
361m
+12.90%
4,313,9013,100,9125,660,58920,266,61415,403,9151,947,8192,854,9883,757,504191,689,000234,265,000276,955,000320,020,000361,295,000
Net income
39m
+47.47%
3,522,5052,244,1124,476,80218,449,54915,968,69215,200,6645,762,66717,955,28611,587,00021,398,00018,986,00026,312,00038,803,000
CFO
47m
+436.78%
1,162,665690,794242,347-42,7391,338,854983,8962,269,4062,215,33022,634,00010,317,00061,483,0008,700,00046,700,000
Dividend
May 10, 20240.35 CHF/sh

Profile

SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions (E&S) and Services and Consumables (S&C). The E&S segment offers mission-critical solutions for the pharmaceutical production, including isolators, integrated automated systems, and aseptic filling systems and solutions, as well as laboratory and cleanroom equipment. The S&C segment provides life cycle support and ready-to-use consumables, as well as customer- specific and digital solutions. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.
URL
https://skan.com/de/home/
IPO date
Apr 05, 2007
Employees
1,269
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
361,295
12.90%
320,020
15.55%
276,955
18.22%
Cost of revenue
110,984
268,118
107,617
Unusual Expense (Income)
NOPBT
250,311
51,902
169,338
NOPBT Margin
69.28%
16.22%
61.14%
Operating Taxes
6,000
4,891
3,796
Tax Rate
2.40%
9.42%
2.24%
NOPAT
244,311
47,011
165,542
Net income
38,803
47.47%
26,312
38.59%
18,986
-11.27%
Dividends
(7,869)
(5,621)
(5,396)
Dividend yield
0.31%
0.38%
Proceeds from repurchase of equity
(880)
BB yield
0.06%
Debt
Debt current
1,094
870
1,608
Long-term debt
14,642
5,804
15,514
Deferred revenue
5,706
5,911
6,727
Other long-term liabilities
686
589
Net debt
(40,606)
(81,628)
(96,111)
Cash flow
Cash from operating activities
46,700
8,700
61,483
CAPEX
(51,026)
(35,298)
(28,865)
Cash from investing activities
(69,057)
(17,346)
(76,418)
Cash from financing activities
(9,349)
(15,801)
(4,846)
FCF
196,111
28,151
150,823
Balance
Cash
61,711
85,122
110,982
Long term investments
(5,369)
3,180
2,251
Excess cash
38,277
72,301
99,385
Stockholders' equity
89,216
59,079
165,595
Invested Capital
180,598
130,368
89,430
ROIC
157.13%
42.78%
204.29%
ROCE
112.29%
26.84%
88.33%
EV
Common stock shares outstanding
22,484
22,484
Price
76.20
-5.69%
80.80
28.25%
63.00
-28.89%
Market cap
1,816,669
28.25%
1,416,462
26.45%
EV
1,742,170
1,328,648
EBITDA
262,790
64,296
180,030
EV/EBITDA
27.10
7.38
Interest
412
464
Interest/NOPBT
0.16%
0.27%